Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Getting chips closer to the bedside

Diagnostic chips for bedside pharmacogenomics are not yet a reality. But Roche and Affymetrix Inc. took one step closer in June when they rolled out the first fruits of their partnership for clinical applications.

The AmpliChip CYP450 DNA microarray is based on AFFX's existing CYP450

Read the full 444 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE